Updated on 27 August 2012
IT Life Sciences Summit in Mumbai on September 6-7, 2012
Mumbai: DIA is hosting the first ‘IT Life Sciences Summit 2012: Technology Enabled Pharmaceutical Business Transformation' on September 6-7, 2012. The two day summit for technology, contract research, pharmaceutical, biotechnology and medical device organizations will take place in Mumbai and focus on technology enabled pharmaceutical business transformation.
Dr Michael Davies, VP, global sales, Oracle Health Sciences, will be the guest of honor at this summit. Key note speakers include Mr Anil Raghavan, MD, Quintiles India, and Mr Sairamkumar J, global delivery head, life sciences, Cognizant.
This summit provides an ideal platform for the life sciences industry, regulators, IT and IT enabled services industry to converge and consider IT intervention for enhancing competiveness; reducing costs and bringing affordable medicines to market. Professions from clinical operations, regulatory affairs, data management, drug safety and pharmacovigilance, manufacturing, finance, sales and marketing, R&D life science companies, IT software, hardware and services organizations are expected to attend this summit.
Globally, pharmaceutical companies are faced with drugs coming off patent, declining R&D productivity, increased regulatory scrutiny, compliance requirements, pricing challenges and the threat of recession. In this backdrop, India has attracted attention in the past decade and especially in the past five years, both as a producer and consumer of pharmaceutical products and services. Global companies are actively looking at India to increase efficiencies across the value chain from increasing market share, clinical development, manufacturing and IT outsourcing. Indigenous local pharmaceutical industry too has made its mark as one of the leading generics manufacturers of world.
The conference will have a number of panel discussions on diverse topics such as how to bring pharma and IT together, smarter manufacturing and supply chain management, pharma compliance, technology, mobility, analytics driven sales and marketing, integrated clinical enterprise, social media and much more. Sessions will also feature expert presentations on the latest trends and technology advances that are reshaping the life sciences industry.